Skip to main content

Table 2 Laboratory examination results of the blood and CSF samples from 11 patients after six cycles of systemic chemotherapy

From: Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis

Parameters

Normal range

Pre-chemotherapy

Post-chemotherapy

Serum NSE, μg/L

0–16.3

91.20 (45.50, 6.20)

31.70 (26.50, 45.60)*

CSF NSE, μg/L

0–16.3

54.60 (31.50, 196.40)

24.00 (9.60, 51.20)

CSF protein, g/L

0.15–0.45

0.34 (0.08, 0.83)

0.30 (0.07, 0.45)

CSF white blood cell, ×106/L

0–10

80.36 ± 18.69

4.27 ± 1.60*

  1. Data are presented as median (Q25, Q75), or mean ± standard deviation. *P < 0.05 versus pre-chemotherapy. CNS: central nervous system; NSE: neurone-specific enolase; CSF: cerebrospinal fluid